Companies

Ocugen, Inc. (OCGN) SEC filings

CIK 0001372299 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)4.4 M6.0 M2.5 M
Net income (USD)-86.8 M-58.4 M
Diluted EPS (USD/shares)-0.26-0.3

Latest filings

FiledFormDescriptionPeriod
2026-10-158-KFORM 8-K items 7.01,9.012026-10-15
2026-10-158-KFORM 8-K items 1.01,7.01,8.01,9.012026-10-13
2026-10-134FORM 42026-10-09
2026-10-09144144
2026-10-068-K8-K items 5.072026-10-05
2026-09-238-K8-K items 5.072026-09-21
2026-09-114FORM 42026-09-09
2026-09-09144144
2026-09-088-KFORM 8-K items 7.01,8.01,9.012026-09-01
2026-08-14DEFA14ADEFA14A
2026-08-13SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-07SCHEDULE 13GSCHEDULE 13G
2026-08-0610-Q10-Q2026-06-30
2026-08-068-KFORM 8-K items 2.02,9.012026-08-06
2026-07-30DEFA14ADEFA 14A
2026-07-30DEF 14ADEF 14A2026-09-21
2026-07-29SCHEDULE 13GSCHEDULE 13G
2026-07-20PRE 14APRE 14A2026-09-21
2026-07-138-KFORM 8-K items 8.01,9.012026-07-13
2026-06-174FORM 42026-06-15
2026-06-154OWNERSHIP DOCUMENT2026-06-11
2026-06-154OWNERSHIP DOCUMENT2026-06-11
2026-06-154OWNERSHIP DOCUMENT2026-06-11
2026-06-154OWNERSHIP DOCUMENT2026-06-11
2026-06-154OWNERSHIP DOCUMENT2026-06-11

Forms on file (last 1,000): 8-K 277, 4 241, 3 44, 10-Q 35, DEFA14A 33, 425 22, SC 13G/A 22, 424B5 18. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=OCGN (0.002 USD), /gw/filings/filings?ticker=OCGN&form=8-K, /gw/filings/facts?ticker=OCGN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange